LP-184

Generic Name: LP-184

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₁₆H_₂₀N_₂O_₄

CAS Number: 924835-67-6

Unique Ingredient Identifier: L683VC69K8

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Study of LP-184 in Patients With Advanced Solid Tumors

Phase 1

Recruiting

Conditions: Advanced Solid Tumor

Interventions: Drug: LP-184

First Posted Date: 2023-07-06

Last Posted Date: 2024-05-16

Lead Sponsor: Lantern Pharma Inc.

Target Recruit Count: 30

Registration Number: NCT05933265

Locations: 🇺🇸
Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States
🇺🇸
UT Health Science Center San Antonio, San Antonio, Texas, United States
🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

and more 6 locations

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy